Rituxan and aspartate aminotransferase increased Patient Reports March 12, 2010

Rituxan Side Effects Report #4583739-7
Rituxan side effect was reported by a Physician from on Jan 28, 2005. Male patient, 51 years of age, weighting 222.0 lb, was diagnosed with vasculitis  and was treated with Rituxan. After drug was administered, patient experienced the following side effects: abdominal discomfort, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, liver function test abnormal, viral load increased. Rituxan dosage: 1000 MG, X2, INTRAVENOUS. Patient recovered.

Rituxan Side Effects Report #5200187-7
Rituxan side effect was reported by a Physician from UNITED STATES on Dec 21, 2006. Male patient, 74 years of age, was diagnosed with rheumatoid arthritis  and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, fatigue. Rituxan dosage: 1000 MG, UNK, INTRAVENOUS. During the same period patient was treated with ARAVA, LISINOPRIL, ATENOLOL, ETODOLAC, FINASTERIDE, FUROSEMIDE, OMEPRAZOLE, TAMSULOSIN. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #5800037-1
Rituxan side effect was reported by a Physician from UNITED STATES on June 25, 2008. Female patient, weighting 156.0 lb, was diagnosed with rheumatoid arthritis  and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased. Rituxan dosage: 1000 MG, UNK. During the same period patient was treated with IMURAN. Patient recovered.

Rituxan Side Effects Report #5152552-4
Rituxan side effect was reported by a Physician from JAPAN on Oct 27, 2006. Female patient, 74 years of age, weighting 88.63 lb, was diagnosed with prophylaxis against transplant rejection and was treated with Rituxan. After drug was administered, patient experienced the following side effects: adenovirus infection, alanine aminotransferase increased, aspartate aminotransferase increased, cystitis haemorrhagic, diarrhoea haemorrhagic, disseminated intravascular coagulation, gastrointestinal haemorrhage, haematocrit decreased, haemoglobin decreased. Rituxan dosage: 100MG/M2, X2, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE, PLATELETS. Patient was hospitalized. Patient died on 07/01/2006.


Rituxan Side Effects Report #4895798-2
Rituxan side effect was reported by a Physician from JAPAN on Jan 11, 2006. Male patient, 83 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, diffuse alveolar damage, haematocrit decreased, interstitial lung disease, lung infiltration, neutrophil percentage decreased, neutrophil percentage increased. Rituxan dosage: 375 MG/M2, INTRAVENOUS. Patient recovered.

Rituxan Side Effects Report #4900862-5
Rituxan side effect was reported by a Physician from JAPAN on Jan 24, 2006. Male patient, 83 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, haematocrit decreased, interstitial lung disease, platelet count decreased, pleural effusion. Rituxan dosage: 375 MG/M2, UNK, INTRAVENOUS. Patient recovered.

Rituxan Side Effects Report #4835746-4
Rituxan side effect was reported by a Physician from JAPAN on Nov 04, 2005. Female patient, 76 years of age, weighting 116.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood lactate dehydrogenase increased, coronary artery occlusion, coronary artery thrombosis, myocardial infarction. Rituxan dosage: 500 MG, IV DRIP. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4810927-4
Rituxan side effect was reported by a Physician from UNITED STATES on Oct 13, 2005. Female patient, 75 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, blood glucose increased, blood sodium decreased, drooling, immune system disorder, laryngitis, lymphopenia. Rituxan dosage: 600 MG,. Patient died on 03/11/2005.

Rituxan Side Effects Report #4818720-3
Rituxan side effect was reported by a Physician from UNITED STATES on Oct 20, 2005. Female patient, 75 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood creatinine decreased, blood glucose increased, blood sodium decreased, cranial nerve disorder, drooling, laryngitis. Rituxan dosage: 375 MG/M2, Q3M. Patient died on 03/11/2005.


Rituxan Side Effects Report #4719167-0
Rituxan side effect was reported by a Health Professional from JAPAN on July 07, 2005. Female patient, 73 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, flatulence, hepatic failure, jaundice , malaise, melaena, tremor. Rituxan dosage: 470 MG, INTRAVENOUS. During the same period patient was treated with KIROSIDE, SACSIZONE. Patient died on 10/25/2003.

Rituxan Side Effects Report #4842684-X
Rituxan side effect was reported by a Health Professional from UNITED STATES on Nov 16, 2005. Male patient, 69 years of age, weighting 177.5 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, alveolitis allergic, amyloidoma, aspartate aminotransferase increased, blood lactate dehydrogenase increased, candidiasis, cd4 lymphocytes decreased, cryptogenic organizing pneumonia. Rituxan dosage: 375 MG/M2, QD, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4933968-5
Rituxan side effect was reported by a Health Professional from UNITED STATES on Mar 01, 2006. Male patient, 69 years of age, weighting 177.5 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, alveolitis allergic, amyloidoma, aspartate aminotransferase increased, blood lactate dehydrogenase increased, candidiasis, cd4 lymphocytes decreased, condition aggravated, cough. Rituxan dosage: 375 MG/M2, QD, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #5264271-4
Rituxan side effect was reported by a Physician from JAPAN on Feb 23, 2007. Male patient, 68 years of age, weighting 152.1 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, gastric ulcer, gastrointestinal haemorrhage, haemoglobin decreased, helicobacter infection. Rituxan dosage: 375 MG, QD, INTRAVENOUS. During the same period patient was treated with FERROMIA, LASIX, ALDACTONE, URSO, OCTOTIAMINE, ASPARA, CHINESE MEDICINE, MOSAPRIDE CITRATE. Patient recovered.

Rituxan Side Effects Report #4923930-0
Rituxan side effect was reported by a Health Professional from JAPAN on Feb 08, 2006. Male patient, 67 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cholecystitis acute, cyanosis, neutropenia, pulse absent, septic shock, white blood cell count decreased. Rituxan dosage: 580 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISOLONE, LOXOPROFEN, METHYLPREDNISOLONE, HYDROCORTISONE. Patient recovered.


Rituxan Side Effects Report #4942941-2
Rituxan side effect was reported by a Physician from JAPAN on Feb 24, 2006. Female patient, 67 years of age, weighting 116.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, haemoglobin decreased, neutrophil count decreased, white blood cell count decreased. Rituxan dosage: 550 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, CYCLOPHOSPHAMIDE, ONCOVIN, BRUFEN, POLARAMINE, NORVASC. Patient recovered.

Rituxan Side Effects Report #4718908-6
Rituxan side effect was reported by a Physician from JAPAN on July 08, 2005. Female patient, 66 years of age, weighting 141.1 lb, was diagnosed with non-hodgkin's lymphoma, diffuse large b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, haemoglobin decreased, nausea , neutrophil count decreased, platelet count decreased. Rituxan dosage: 590 MG, INTRAVENOUS. During the same period patient was treated with IFOSFAMIDE, PARAPLATIN, VEPESID, MESNA, POLARAMINE, IBUPROFEN. Patient recovered.

Rituxan Side Effects Report #4868781-0
Rituxan side effect was reported by a Consumer or non-health professional from JAPAN on Dec 14, 2005. Male patient, 65 years of age, weighting 136.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gangrene, haemoglobin decreased, hepatic function abnormal. Rituxan dosage: 650 MG, INTRAVENOUS. During the same period patient was treated with THERARUBICIN, CYCLOPHOSPHAMIDE, ONCOVIN, METHOTREXATE, FAMOTIDINE, TEGRETOL, VERAPAMIL, ISONIAZID. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4902361-3
Rituxan side effect was reported by a Consumer or non-health professional from JAPAN on Jan 20, 2006. Male patient, 65 years of age, weighting 136.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gangrene, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Rituxan dosage: 650 MG, INTRAVENOUS. During the same period patient was treated with THERARUBICIN, ENDOXAN, ONCOVIN, METHOTREXATE, FAMOTIDINE, TEGRETOL, VERAPAMIL, ISONIAZID. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4911383-8
Rituxan side effect was reported by a Physician from JAPAN on Feb 06, 2006. Male patient, 65 years of age, weighting 136.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gangrene, haemoglobin decreased, hepatic function abnormal, platelet count decreased, white blood cell count decreased. Rituxan dosage: 650 MG, INTRAVENOUS. During the same period patient was treated with THERARUBICIN, ENDOXAN, ONCOVIN, METHOTREXATE, FAMOTIDINE, TEGRETOL, VERAPAMIL, ISONIAZID. Patient was hospitalized. Patient recovered.


Rituxan Side Effects Report #4930277-5
Rituxan side effect was reported by a Physician from JAPAN on Feb 15, 2006. Male patient, 65 years of age, weighting 136.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, diabetic gangrene, haemoglobin decreased, hepatic function abnormal, platelet count decreased, white blood cell count decreased. Rituxan dosage: 650 MG, INTRAVENOUS. During the same period patient was treated with THERARUBICIN, ENDOXAN, ONCOVIN, METHOTREXATE, FAMOTIDINE, TEGRETOL, VERAPAMIL, ISONIAZID. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4933998-3
Rituxan side effect was reported by a Physician from JAPAN on Mar 01, 2006. Male patient, 65 years of age, weighting 136.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gangrene, haemoglobin decreased, hepatic function abnormal, platelet count decreased, white blood cell count decreased. Rituxan dosage: 650 MG, INTRAVENOUS. During the same period patient was treated with THERARUBICIN, ENDOXAN, ONCOVIN, METHOTREXATE, FAMOTIDINE, TEGRETOL, VERAPAMIL, ISONIAZID. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4724607-7
Rituxan side effect was reported by a Physician from JAPAN on July 08, 2005. Male patient, 64 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, white blood cell count decreased. Rituxan dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, PREDNISONE. Patient recovered.

Rituxan Side Effects Report #4759315-X
Rituxan side effect was reported by a Physician from JAPAN on Aug 26, 2005. Male patient, 64 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, hepatic function abnormal, white blood cell count decreased. Rituxan dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, PREDNISONE. Patient recovered.

Rituxan Side Effects Report #4669462-9
Rituxan side effect was reported by a Physician from on May 09, 2005. Male patient, 62 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal, pancytopenia. Rituxan dosage: 500 MG, INTRAVENOUS. During the same period patient was treated with CLADRIBINE, MITOXANTRONE, DEXAMETHASONE, ALLOPURINOL, ROXATIDINE. Patient was hospitalized. Patient recovered.


Rituxan Side Effects Report #4719213-4
Rituxan side effect was reported by a Physician from JAPAN on July 08, 2005. Female patient, 51 years of age, weighting 185.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, headache , neuropathy peripheral, neutrophil count decreased, pyrexia, white blood cell count decreased. Rituxan dosage: 720 MG 1/WEEK INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE, FAMOTIDINE. Patient recovered.

Rituxan Side Effects Report #4729598-0
Rituxan side effect was reported by a Physician from JAPAN on July 15, 2005. Male patient, 49 years of age, weighting 127.9 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, chills, cough, neutrophil count decreased, pruritus, pyrexia, white blood cell count decreased. Rituxan dosage: 600 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, HYDROCORTISONE SUCCINATE, VENA, CALONAL, ZOFRAN. Patient recovered.

Rituxan Side Effects Report #5258583-8
Rituxan side effect was reported by a Health Professional from UNITED STATES on Feb 20, 2007. Female patient, 47 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, coma, dysarthria, encephalitis herpes, encephalopathy, false negative laboratory result, gliosis. Rituxan dosage: 375 MG/M2, UNK, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE. Patient was hospitalized. Patient died.

Rituxan Side Effects Report #5291837-8
Rituxan side effect was reported by a Physician from UNITED STATES on Mar 22, 2007. Female patient, 47 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cerebral ischaemia, coma, dysarthria, encephalitis , encephalitis herpes, false negative laboratory result, gliosis. Rituxan dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE. Patient was hospitalized. Patient died on 03/17/2003.

Rituxan Side Effects Report #4678187-5
Rituxan side effect was reported by a Physician from on May 18, 2005. Female patient, 47 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, disseminated intravascular coagulation, hepatic function abnormal. Rituxan dosage: 600 MG, INTRAVENOUS. Patient recovered.


Rituxan Side Effects Report #4678188-7
Rituxan side effect was reported by a Physician from on May 18, 2005. Female patient, 47 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, disseminated intravascular coagulation, hepatic function abnormal. Rituxan dosage: 600 MG, INTRAVENOUS. Patient recovered.

Rituxan Side Effects Report #4698865-1
Rituxan side effect was reported by a Physician from on June 09, 2005. Female patient, 47 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: abdominal pain upper, alanine aminotransferase increased, aspartate aminotransferase increased, chills, disseminated intravascular coagulation, fatigue, haematocrit decreased, haemoglobin decreased, headache . Rituxan dosage: 600 MG, INTRAVENOUS. During the same period patient was treated with POLARAMINE, CALONAL, FAMOTIDINE, SELBEX, BIOFERMIN, POTASSIUM CITRATE, ALLOPURINOL, FERROMIA. Patient recovered.

Rituxan Side Effects Report #4700712-6
Rituxan side effect was reported by a Physician from on June 09, 2005. Female patient, 47 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: abdominal pain upper, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, chills, disseminated intravascular coagulation, fatigue, headache . Rituxan dosage: 600 MG, INTRAVENOUS. During the same period patient was treated with SALINE, POLARAMINE, CALONAL, FAMOTIDINE, SELBEX, BIOFERMIN, URALYT. Patient recovered.

Rituxan Side Effects Report #4749074-9
Rituxan side effect was reported by a Physician from JAPAN on Aug 05, 2005. Female patient, 47 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: abdominal pain upper, alanine aminotransferase increased, aspartate aminotransferase increased, chills, condition aggravated, disseminated intravascular coagulation, fatigue, haematocrit decreased, haemoglobin decreased. Rituxan dosage: 600 MG, INTRAVENOUS. During the same period patient was treated with POLARAMINE, CALONAL, FAMOTIDINE, SELBEX, BIOFERMIN, POTASSIUM CITRATE, ALLOPURINOL, FERROMIA. Patient recovered.

Rituxan Side Effects Report #4698863-8
Rituxan side effect was reported by a Physician from on June 07, 2005. Female patient, 43 years of age, weighting 103.6 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. Rituxan dosage: 500 MG, IV DRIP. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN HYDROCHLORIDE, PREDNISONE, FAMOTIDINE, MUCOSTA, ALLOPURINOL, POLARAMINE. Patient was hospitalized. Patient recovered.


Rituxan Side Effects Report #4716494-8
Rituxan side effect was reported by a Physician from JAPAN on July 01, 2005. Female patient, 43 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased. Rituxan dosage: 500 MG, IV DRIP. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN HYDROCHLORIDE, PREDNISONE, FAMOTIDINE, MUCOSTA, ALLOPURINOL, POLARAMINE. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4789229-0
Rituxan side effect was reported by a Health Professional from UNITED STATES on Sept 19, 2005. Female patient, 40 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic enzyme increased, pyrexia, transaminases increased. Rituxan dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient recovered.

Rituxan Side Effects Report #4798350-2
Rituxan side effect was reported by a Health Professional from UNITED STATES on Sept 26, 2005. Female patient, 40 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, arthralgia, aspartate aminotransferase increased, blood alkaline phosphatase increased, chills, fatigue, pyrexia. Rituxan dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, ANZEMET, COMPAZINE, NEULASTA. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4780995-7
Rituxan side effect was reported by a Physician from JAPAN on Sept 13, 2005. Female patient, 36 years of age, weighting 125.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, dizziness , gamma-glutamyltransferase increased, haemoglobin decreased, headache , infection , nausea , neutrophil count decreased. Rituxan dosage: 585 MG, INTRAVENOUS. During the same period patient was treated with IFOSFAMIDE, PARAPLATIN, VEPESID, IBRUFEN, POLARAMINE, NEUTROGIN, MAGNESIUM OXIDE, PURSENNID. Patient recovered.

Rituxan Side Effects Report #5511694-1
Rituxan side effect was reported by a Consumer or non-health professional from JAPAN on Nov 02, 2007. Female patient, weighting 127.9 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, condition aggravated, dyspnoea, hepatitis b , infection , nausea . Rituxan dosage: 600 MG, UNK. During the same period patient was treated with DEXAMETHASONE, FLUDARABINE PHOSPHATE, MITOXANTRONE, METHYLPREDNISOLONE SUCCINATE, CHLORPHENIRAMINE MALEATE. Patient was hospitalized. Patient recovered.


Rituxan Side Effects Report #5122269-0
Rituxan side effect was reported by a Health Professional from UNITED STATES on Sept 22, 2006. Female patient, 83 years of age, was diagnosed with lymphoma  and was treated with Rituxan. After drug was administered, patient experienced the following side effects: abdominal pain , abscess , anorexia, aspartate aminotransferase increased, blood albumin decreased, blood bicarbonate decreased, blood calcium decreased, blood gases abnormal, blood glucose increased. Rituxan dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with CYTOXAN, NOVANTRONE, ONCOVIN, PREDNISONE, PROCRIT, DIFLUCAN, ATROVENT, PREVACID. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4967441-5
Rituxan side effect was reported by a Physician from JAPAN on Mar 22, 2006. Male patient, 75 years of age, weighting 110.2 lb, was diagnosed with lymphoma  and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, c-reactive protein increased, hepatic function abnormal, pneumocystis jiroveci pneumonia, white blood cell count decreased. Rituxan dosage: 550 MG, INTRAVENOUS. During the same period patient was treated with ENDOXAN, ONCOVIN, PREDONINE, PIRARUBICIN, IBUPROFEN, HYDROXYZINE PAMOATE, HYDROCORTISONE SUCCINATE, ZOLPIDEM TARTRATE. Patient recovered.

Rituxan Side Effects Report #4625806-5
Rituxan side effect was reported by a Physician from on Mar 28, 2005. Female patient, 46 years of age, weighting 137.8 lb, was diagnosed with extranodal marginal zone b-cell lymphoma (malt type) and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, liver disorder, urinary tract infection , viral infection , vomiting. Rituxan dosage: 600 MG, INTRAVENOUS. During the same period patient was treated with CHLORPHENIRAMINE MALEATE, ACETAMINOPHEN, LOXOPROFEN. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4788910-7
Rituxan side effect was reported by a Physician from JAPAN on Sept 20, 2005. Male patient, 73 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, duodenal ulcer perforation, hepatic function abnormal, hepatitis b , multi-organ failure, post procedural complication. Rituxan dosage: unknown. During the same period patient was treated with PIRARUBICIN, CYCLOPHOSPHAMIDE, VINCRISTINE SULPHATE, PREDNISONE. Patient died.

Rituxan Side Effects Report #4704424-4
Rituxan side effect was reported by a Physician from on June 13, 2005. Female patient, 66 years of age, weighting 125.7 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, neutrophil count decreased, pyrexia, white blood cell count decreased. Rituxan dosage: 585 MG, 1/MONTH, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISOLONE PHOSPHATE, IBUPROFEN, POLARAMINE, SAXIZON. Patient recovered.

Rituxan Side Effects Report #4730132-X
Rituxan side effect was reported by a Physician from JAPAN on July 20, 2005. Female patient, 66 years of age, weighting 125.7 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, neutrophil count decreased, neutrophil percentage increased, pyrexia, white blood cell count decreased. Rituxan dosage: 585 MG, 1/MONTH, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISOLONE SUCCINATE, IBUPROFEN, POLARAMINE, SAXIZON. Patient recovered.

Rituxan Side Effects Report #4745084-6
Rituxan side effect was reported by a Physician from JAPAN on Aug 03, 2005. Female patient, 66 years of age, weighting 125.7 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, neutrophil count decreased, pyrexia, white blood cell count decreased. Rituxan dosage: 585 MG, 1/MONTH, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, ONCOVIN, PREDONINE, IBUPROFEN, POLARAMINE, SAXIZON, MAGNESIUM OXIDE. Patient recovered.

Rituxan Side Effects Report #4952052-8
Rituxan side effect was reported by a Physician from JAPAN on Mar 08, 2006. Female patient, 48 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase, gamma-glutamyltransferase increased, liver disorder, urticaria. Rituxan dosage: 600 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, ONCOVIN, ENDOXAN, PREDONINE, POLARAMINE, LOXONIN, MODACIN, MEROPEN. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4562915-3
Rituxan side effect was reported by a Health Professional from on Jan 14, 2005. Female patient, 68 years of age, was diagnosed with b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anuria, aspartate aminotransferase increased, blood bilirubin increased, blood lactate dehydrogenase increased, blood pressure decreased, blood urea increased, cardiac failure, haemosiderosis. Rituxan dosage: 500 MG 2/MONTH INTRAVENOUS. During the same period patient was treated with LEVOTHYROXIN, ANTIFUNGAL, DOPAMINE, GRANISETRON, DOBUTAMINE, DEXAMETHASONE, IMIPENEM. Patient died on 07/16/2003.

Rituxan Side Effects Report #4562917-7
Rituxan side effect was reported by a Health Professional from on Jan 14, 2005. Female patient, 68 years of age, was diagnosed with b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anuria, aspartate aminotransferase increased, blood bilirubin increased, blood lactate dehydrogenase increased, blood pressure decreased, cardiac failure, condition aggravated, hepatic function abnormal. Rituxan dosage: 500 MG X2 INTRAVENOUS. During the same period patient was treated with COLDREX, LEVOTHYROXIN, FAMOTIDINE, SULFAMETHOXAZOLE, DOPAMINE, GRANISETRON, DEXAMETHASONE, ANTIFUNGAL. Patient died on 07/16/2003.


Rituxan Side Effects Report #5500007-7
Rituxan side effect was reported by a Physician from PORTUGAL on Oct 19, 2007. Female patient, 66 years of age, weighting 99.21 lb, was diagnosed with rheumatoid arthritis  and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, bone marrow failure, gamma-glutamyltransferase increased, hypovolaemia, ischaemia, pancytopenia. Rituxan dosage: unknown. During the same period patient was treated with METHOTREXATE, FOLIC ACID, MEDROL, FUROSEMIDE. Patient was hospitalized and became disabled. Patient recovered.